Literature DB >> 11907715

Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures.

M Grano1, G Mori, V Minielli, O Barou, S Colucci, G Giannelli, C Alexandre, A Z Zallone, L Vico.   

Abstract

In this research we utilized tail-suspended rats as an in vivo model for bone loss studies in order to investigate the effects of the tail suspension on the structure of the suspended bones and in ex vivo cultures the activities of trabecular osteoblasts, marrow-derived osteogenic cells, and osteoclasts obtained from treated animals, compared with untreated controls. After a 5-day hind limb unloading, trabecular thinning was already evidenced in the tibial primary spongiosa. In the secondary spongiosa, the bone formation activity was reduced whereas osteoclastic parameters were not yet altered. Bone marrow-derived osteogenic cells and differentiated osteoblasts from enzymatic digestion of posterior limb trabecular bone were prepared from 5 day tail-suspended rats and from normally loaded rats as controls. Cell morphology, alkaline phosphatase (ALPH) activity, production of mineral matrix, osteocalcin, and IL-6 secretion were evaluated in both cell populations. Tail suspension reduced the osteogenic potential of stromal marrow cells and of already differentiated osteoblasts. In fact, ALP positive colonies were significantly reduced in number and were smaller in size compared with controls and bone nodules formed in permissive conditions were also significantly fewer and smaller, whereas in cultures of cells from control conditions, large mineralizing nodules were formed. Osteocalcin secretion was not affected by unloading. Finally, IL-6 concentration was increased in marrow-derived cells from treated rats compared with controls. Primary cultures of osteoclasts were obtained from the nonadherent fraction of the bone marrow of the same animals. The number of TRAP positive cells in culture from tail-suspended rats was significantly increased, as well as bone resorption activity, measured as resorbed surfaces of a suitable synthetic hydroxyapatite, compared with controls. These data clearly suggest that skeletal unloading not only reduces the osteogenic potential of osteoblastic cells but induces an increased osteoclastogenesis and osteoclast activity in ex vivo cultures. They also indicate for the first time that a possible mediator responsible for the increased osteoclastogenesis could be represented by the IL-6 whose secretion by bone marrow cells was significantly enhanced by unloading.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907715     DOI: 10.1007/s00223-001-2034-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  21 in total

1.  Simulated spaceflight produces a rapid and sustained loss of osteoprogenitors and an acute but transitory rise of osteoclast precursors in two genetic strains of mice.

Authors:  Mohammad Shahnazari; Pam Kurimoto; Benjamin M Boudignon; Benjamin E Orwoll; Daniel D Bikle; Bernard P Halloran
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-09       Impact factor: 4.310

2.  Down-regulation of N-methyl D-aspartate receptor in rat-modeled disuse osteopenia.

Authors:  Mei-Ling Ho; Tsen-Ni Tsai; Je-Ken Chang; Tin-Sin Shao; Yung-Ru Jeng; Chin Hsu
Journal:  Osteoporos Int       Date:  2005-07-05       Impact factor: 4.507

3.  Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading.

Authors:  M W Hamrick; X Shi; W Zhang; C Pennington; H Thakore; M Haque; B Kang; C M Isales; S Fulzele; K H Wenger
Journal:  Bone       Date:  2007-02-23       Impact factor: 4.398

4.  Absence of mechanical loading in utero influences bone mass and architecture but not innervation in Myod-Myf5-deficient mice.

Authors:  Cédric Gomez; Valentin David; Nicola M Peet; Laurence Vico; Chantal Chenu; Luc Malaval; Timothy M Skerry
Journal:  J Anat       Date:  2007-03       Impact factor: 2.610

5.  A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives.

Authors:  Elvira De Giglio; Stefania Cometa; Cosima-Damiana Calvano; Luigia Sabbatini; Pier Giorgio Zambonin; Silvia Colucci; Adriana Di Benedetto; Graziana Colaianni
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

6.  Oxidative stress and gamma radiation-induced cancellous bone loss with musculoskeletal disuse.

Authors:  Hisataka Kondo; Kenji Yumoto; Joshua S Alwood; Rose Mojarrab; Angela Wang; Eduardo A C Almeida; Nancy D Searby; Charles L Limoli; Ruth K Globus
Journal:  J Appl Physiol (1985)       Date:  2009-10-29

7.  Metaphyseal and diaphyseal bone loss in the tibia following transient muscle paralysis are spatiotemporally distinct resorption events.

Authors:  Brandon J Ausk; Philippe Huber; Sundar Srinivasan; Steven D Bain; Ronald Y Kwon; Erin A McNamara; Sandra L Poliachik; Christian L Sybrowsky; Ted S Gross
Journal:  Bone       Date:  2013-09-21       Impact factor: 4.398

8.  Osteophytes and fracture calluses share developmental milestones and are diminished by unloading.

Authors:  Allison W Hsia; Armaun J Emami; Franklin D Tarke; Hailey C Cunningham; Priscilla M Tjandra; Alice Wong; Blaine A Christiansen; Nicole M Collette
Journal:  J Orthop Res       Date:  2017-11-22       Impact factor: 3.494

Review 9.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

10.  Intermittent posterior displacement of the rat mandible in the growth period affects the condylar cancellous bone.

Authors:  Yukiko Kuroda; Ikuo Yonemitsu; Jun Hosomichi; Ippei Watari; Maki Takei; Yuji Ishida; Takashi Ono
Journal:  Angle Orthod       Date:  2011-06-09       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.